2D-DIGE as a strategy to identify serum protein biomarkers to monitor pharmacological efficacy in dopamine-dictated states of Parkinson’s disease and schizophrenia

OBJECTIVES: Parkinson’s disease and schizophrenia are clinical scenarios that occur due to dopaminergic deficit and hyperactivity in the midbrain, respectively. Current pharmacological interventions for these two diseases therefore aim to restore normal dopamine levels in the midbrain. But during th...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuropsychiatr Dis Treat
Autori principali: Gupta, Ashish Kumar, Kumar, Gaurav Khunger, Rani, Komal, Pokhriyal, Ruchika, Khan, Mohd Imran, Kumar, Domada Ratna, Goyal, Vinay, Tripathi, Manjari, Gupta, Rishab, Chadda, Rakesh Kumar, Vanamail, Perumal, Mohanty, Ashok Kumar, Hariprasad, Gururao
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2019
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6488160/
https://ncbi.nlm.nih.gov/pubmed/31114209
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S198559
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi